Clinical AI has moved past experimentation and into everyday operations at healthcare technology and life sciences companies. It is used to reduce administrative burden, expand capacity, improve documentation, and surface clinical insight faster.
The first adoption wave of clinical AI focused on proof of value: Can the technology help clinicians, accelerate workflows, or increase capacity? The next question is whether it can do those things affordably, reliably, and at scale.
That requires managing not just the model cost, but the economics of the overall AI workflow.
The cost of clinical AI is more than the price of a token
In clinical AI, the cost of running the model is becoming a fundamental business problem, directly impacting product and architecture decisions. Forbes has described token consumption and inference cost as an emerging rate limiter for generative clinical tools, while Gartner projects increased consumption and consumption-based licensing will make costs harder to predict and control.
The cost of an AI workflow is not simply the posted price of a token. It depends on model tier, whether the model is proprietary or open-weight, context length, input context size, number of calls, and how often the same patient or clinical context is sent back through the system. Two tools may both be labeled “AI,” yet carry very different margin profiles.
That is why healthcare AI leaders should manage cost per trusted completed task, not just cost per token.
Cheaper models won’t necessarily mean cheaper AI
Lower model prices will not automatically mean lower AI budgets. Cheaper performance often begets broader use, larger deployments, and more ambitious workflows. In healthcare, that can mean longer encounters, longitudinal records, specialty-specific evidence, prior authorization histories, medications, labs, imaging reports, and claims data entering the workflow. Unit prices may fall while total consumption rises.
Clinical context comes at a cost
The difference between a useful answer and an unsafe or generic one often depends on whether the system has the right clinical facts, patient history, specialty knowledge, and workflow context.
As use cases move from note drafting to coding, utilization management, risk adjustment, care gap closure, research, and decision support, demand for context and reasoning will increase.
But more context isn’t automatically better context. Sending everything available through the model can increase token consumption without necessarily giving it the specific information required to complete the task. The challenge is to make clinical context relevant, structured, and usable before inference begins.
Architecture is becoming an economic decision
Product teams decide how much cognitive load belongs to the model versus the surrounding system, and which problems require probabilistic reasoning versus deterministic knowledge.
The system can select evidence, normalize clinical concepts, apply rules, structure inputs, and route tasks before inference begins. The goal is not to give the model less information; it is to give it better information so expensive reasoning is reserved for where it creates value.
Instead of asking a model to reconstruct established clinical knowledge with every inference, applications can provide that knowledge directly and reserve model reasoning for the work that truly requires it.
Companies that treat inference as invisible infrastructure may find that adoption success creates its own cost problem. Clinically validated knowledge sources, such as IMO Health’s Knowledge Graph, can reduce the cognitive load placed on large language models (LLMs) and small language models (SLMs), provide trusted and deterministic knowledge where appropriate, improve accuracy and explainability, and give product teams more flexibility to choose the right model and architecture for each task.
Ultimately, the winners in clinical AI may not be the companies using the cheapest models. They may be the ones that become most disciplined about where they use models at all. The real unit of value isn’t the token. It’s the trusted clinical task completed at a cost the business can sustain.
